BR112019006339A2 - interferons tipo iii variantes e sintecinas - Google Patents

interferons tipo iii variantes e sintecinas

Info

Publication number
BR112019006339A2
BR112019006339A2 BR112019006339A BR112019006339A BR112019006339A2 BR 112019006339 A2 BR112019006339 A2 BR 112019006339A2 BR 112019006339 A BR112019006339 A BR 112019006339A BR 112019006339 A BR112019006339 A BR 112019006339A BR 112019006339 A2 BR112019006339 A2 BR 112019006339A2
Authority
BR
Brazil
Prior art keywords
type iii
synthecins
iii variants
interferons
interferons type
Prior art date
Application number
BR112019006339A
Other languages
English (en)
Inventor
Luis Mendoza Juan
Christopher Garcia Kenan
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of BR112019006339A2 publication Critical patent/BR112019006339A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)

Abstract

são fornecidos composições e métodos relativos a interferons tipo iii.
BR112019006339A 2016-09-30 2017-09-29 interferons tipo iii variantes e sintecinas BR112019006339A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662402204P 2016-09-30 2016-09-30
PCT/US2017/054498 WO2018064574A1 (en) 2016-09-30 2017-09-29 Variant type iii interferons and synthekines

Publications (1)

Publication Number Publication Date
BR112019006339A2 true BR112019006339A2 (pt) 2019-10-01

Family

ID=61760153

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019006339A BR112019006339A2 (pt) 2016-09-30 2017-09-29 interferons tipo iii variantes e sintecinas

Country Status (12)

Country Link
US (2) US11198717B2 (pt)
EP (1) EP3518958A4 (pt)
JP (2) JP2019531729A (pt)
KR (1) KR20190062490A (pt)
CN (1) CN109982714A (pt)
AU (1) AU2017336078B2 (pt)
BR (1) BR112019006339A2 (pt)
CA (1) CA3038533A1 (pt)
IL (1) IL265622A (pt)
MX (1) MX2019003744A (pt)
WO (1) WO2018064574A1 (pt)
ZA (1) ZA201902093B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220035365A (ko) 2019-07-18 2022-03-22 엔요 파마 인터페론의 부작용을 감소시키는 방법
CN111407883B (zh) * 2020-05-26 2024-01-12 南通大学 IFN-λ3在刚地弓形虫感染中的新用途
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448993C (zh) * 2000-06-30 2009-01-07 津莫吉尼蒂克斯公司 干扰素样蛋白质Zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
AU2003215136A1 (en) * 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
DK1668031T3 (da) * 2003-08-07 2008-06-30 Zymogenetics Inc Homogene præparater af IL-29
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
GB0715383D0 (en) * 2007-08-08 2007-09-19 Asterion Ltd Interferon
US20120308517A1 (en) * 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases
US9738696B2 (en) * 2012-08-09 2017-08-22 The Board Of Trustees Of The Leland Stanford Junior University Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
CN104968673B (zh) * 2014-01-08 2018-11-02 德益阳光生物技术（北京）有限责任公司 融合多肽及使用方法

Also Published As

Publication number Publication date
EP3518958A1 (en) 2019-08-07
US20190225665A1 (en) 2019-07-25
ZA201902093B (en) 2021-08-25
US11198717B2 (en) 2021-12-14
US20220041675A1 (en) 2022-02-10
WO2018064574A1 (en) 2018-04-05
MX2019003744A (es) 2019-10-30
JP2019531729A (ja) 2019-11-07
CN109982714A (zh) 2019-07-05
KR20190062490A (ko) 2019-06-05
AU2017336078B2 (en) 2022-07-21
EP3518958A4 (en) 2021-03-31
CA3038533A1 (en) 2018-04-05
AU2017336078A1 (en) 2019-04-18
IL265622A (en) 2019-05-30
JP2022191416A (ja) 2022-12-27

Similar Documents

Publication Publication Date Title
MA46458A (fr) Compositions debacillus thuringiensis
EA201891211A1 (ru) Ингибиторы cxcr2
DK3697376T3 (da) Sammensætning
DK3361870T3 (da) Fungicidsammensætninger
CY1124425T1 (el) Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
DK3892302T3 (da) Sammensætninger indeholdende ibrutinib
DK3416996T3 (da) Hærdelig sammensætning
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
DK3528902T3 (da) Ringegelsammensætning
MA45090A (fr) Compositions anticancéreuses
EA202092926A3 (ru) Лиофилизированные составы, содержащие фактор ix
DK3331498T3 (da) Nasalsammensætning
DK3397734T3 (da) Brændstofsammensætning
DK3316857T3 (da) Multifasiske sammensætninger
BR112019006339A2 (pt) interferons tipo iii variantes e sintecinas
DK3551196T3 (da) Probiotiske immunmodulerende sammensætninger
DK3609464T3 (da) Xanthohumolbaserede sammensætninger
DK3554474T3 (da) Micafungin-sammensætninger
DK3528791T3 (da) Dispergible sammensætninger
DE112017005633A5 (de) Dichtungsanordnung
DK3402573T3 (da) Aminosyreholdig sammensætning
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
DK3337322T3 (da) Fungicidsammensætninger

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.